First cycle toxicity and survival in patients with rare cancers treated with checkpoint inhibitors is a dataset published in JNCI Journal of the National Cancer Institute (2024). On theSindex it has a DataRank of 0.385, placing it in the top 47.1% of the data-sharing corpus. It has been cited 8 times, with 6 citing works in its 1-hop citation network.
Ranks in the top 47% for downstream scientific impact
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.330
From this paper's citation signal
Citation Network Contribution
0.0558
From 3 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 6 citers.
National Cancer Institute
Grant: U10CA180888
National Cancer Institute
Grant: U10CA180819
Bristol-Myers Squibb Company
Grant: 5U01CA180888-08
Bristol-Myers Squibb Company
Grant: 5UG1CA233198-05
NCI NIH HHS
Grant: UG1 CA233198
NIH HHS
National Institutes of Health
NIH HHS
FWCI
1.38
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals